The Role of Adjuvant Chemotherapy in Endometrial Cancer Following Preoperative Neoadjuvant Chemoradiation Therapy
After receiving neoadjuvant CRT or RT for advanced and high-grade endometrial cancers, adjuvant chemotherapy was not predictive of improved OS, but was predictive of worse DFS. A larger cohort and longer follow-up are needed to ascertain whether certain high-risk subgroups of patients benefit from adjuvant chemotherapy.
Authors
- Sarah A. Taylor (ORCID: https://orcid.org/0000-0002-3575-8386)
- Michelle Ertel (ORCID: https://orcid.org/0000-0003-4337-4814)
- M.M. Boisen (ORCID: https://orcid.org/0000-0002-9782-5345)
- Jamie Lesnock
- Margaret Flanigan (ORCID: https://orcid.org/0000-0003-3706-4334)
- Paniti Sukumvanich (ORCID: https://orcid.org/0000-0001-5555-8667)
- Shannon Rush (ORCID: https://orcid.org/0000-0003-2310-7137)
- Li Wang (ORCID: https://orcid.org/0000-0003-0588-5234)
- John A. Vargo (ORCID: https://orcid.org/0000-0002-0707-9239)
Institutions
- University of Pittsburgh (US)
- Magee-Womens Hospital (US)
Publication Details
- Journal
- American Journal of Clinical Oncology
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1097/coc.0000000000001205
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00